Dr. Yilie Liao | Metabolism | Best Researcher Award

Dr. Yilie Liao | Metabolism | Best Researcher Award

Dr. Yilie Liao, Zhongshan Institute for Drug Discovery (ZIDD), China

Yilie Liao is an accomplished scientist specializing in metabolic research and integrative biology. Currently, she serves as an Assistant Research Scientist at the Zhongshan Institute for Drug Discovery under the Shanghai Institute of Materia Medica, part of the Chinese Academy of Sciences. With a Ph.D. in Biology from Tsinghua University, Yilie has a rich background in life sciences, particularly focusing on metabolic disease, neurodevelopment, and tumorigenesis. Her research, conducted in collaboration with leading institutions, including Duke-NUS Medical School, delves into metabolic reprogramming, revealing significant insights into the biological mechanisms underlying health and disease. She is recognized for her innovative approach, evidenced by her pioneering work in metabolic pathways and proteomic studies. Through her dedication to research and collaboration, Yilie continues to push the boundaries of biological sciences, making notable contributions to the understanding and potential treatments for complex metabolic conditions.

Professional Profile

Orcid

Suitability for the Research for Best Researcher Award

Yilie Liao’s dedication to addressing vital biological questions in metabolic health and his breadth of expertise in both technical and conceptual aspects of biology position him as an exceptional candidate for the Research for Best Researcher Award. His innovative findings, technical versatility, and contributions to high-impact publications underscore his potential for continued advancements in biology.

🎓  Education 

Yilie Liao obtained her Ph.D. in Biology from the School of Life Sciences at Tsinghua University in 2020, where she conducted groundbreaking research under the mentorship of Dr. Suneng Fu. Her doctoral studies focused on metabolic reprogramming in metabolic diseases and neural development. Previously, she earned her B.Sc. in Biological Science from Nanjing Agricultural University in 2013. Her undergraduate education laid the foundation for her interest in integrative biology and metabolic research. Throughout her academic journey, Yilie acquired a robust skill set, encompassing molecular biology techniques, data analysis, and metabolomic profiling. Her proficiency in multi-omics data analysis, combined with a strong foundation in biological sciences, has enabled her to explore complex biochemical pathways and cellular processes. Her educational background reflects her commitment to advancing scientific knowledge and tackling complex issues in metabolic diseases and cellular biology.

💼   Experience

Yilie Liao’s research career spans several prestigious institutions and roles, each contributing to her expertise in metabolic biology. She is currently an Assistant Research Scientist at Zhongshan Institute for Drug Discovery under the Shanghai Institute of Materia Medica. From 2021 to 2023, she worked as a Postdoctoral Fellow at Bioland Laboratories, investigating neurodevelopmental and metabolic disease mechanisms under Prof. Peng Li. In 2022, she was a visiting researcher at Duke-NUS Medical School, exploring novel metabolic pathways with renowned scientists Prof. Weiping Han and Dr. Alfred Sun. Her projects have included identifying SLC transporters in the central nervous system and studying metabolic substrates impacting liver and brain health. Through these roles, Yilie has acquired extensive experience in experimental design, data mining, and integrative biology, making her a leading expert in her field with substantial contributions to metabolic disease research.

🏅 Awards and Honors 

Yilie Liao’s contributions to metabolic biology and her dedication to advancing scientific understanding have earned her numerous accolades. Her work on hepatic lipogenesis and metabolic reprogramming has been recognized with prestigious awards from leading scientific societies, highlighting her impact in biomedical research. She has received notable recognition from the Chinese Academy of Sciences for her innovative work in translational research and metabolic disease. As a testament to her expertise, she has been a recipient of research grants supporting her studies on cellular metabolism, neurodevelopment, and tumorigenesis. Yilie’s publications in high-impact journals such as Cell Metabolism and Hepatology further underscore her prominence in the field. Her academic and professional honors reflect her commitment to scientific excellence and her potential to drive significant advancements in biological and metabolic research.

🌍 Research Focus

Yilie Liao’s research centers on uncovering the intricate mechanisms of metabolic reprogramming in health and disease. She investigates how metabolic pathways influence conditions such as obesity, neurodevelopmental disorders, and cancer, with a particular focus on the role of amino acids in hepatic lipogenesis. Her recent work explores SLC transporters’ influence in the central nervous system and their impact on brain functions. Additionally, her research extends to the identification of metabolic markers in Alzheimer’s disease, using single-cell sequencing to reveal early dysfunctions. She is also involved in studying tumor microenvironment metabolic changes, with implications for early diagnosis and treatment of liver cancer. Through her work, Yilie aims to provide insight into metabolic diseases and develop novel therapeutic approaches that address metabolic imbalances, contributing to the broader field of translational medicine.

📖 Publication Top Notes

  • Amino acid is a major carbon source for hepatic lipogenesis
  • Hepatic mitochondrial NAD+ transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis
  • Genetic Ablation of LAT1 Inhibits Growth of Liver Cancer Cells and Downregulates mTORC1 Signaling

Mr. Malu Daniel | Biotechnology | Research Excellence Award

Mr. Malu Daniel | Biotechnology | Research Excellence Award

Mr. Malu Daniel, University of Calabar, Calabar, Nigeria, Nigeria

MR. DANIEL GATIE MALU is a dynamic researcher with a B.Sc. in Genetics and Biotechnology from the University of Calabar, Nigeria. His expertise lies in drug design, discovery, and molecular docking, where he utilizes computational techniques such as density functional theory (DFT) to address complex scientific challenges. His passion for drug delivery systems, particularly for genetic disorders like Cystic Fibrosis and cancers, fuels his ongoing research. Throughout his academic journey, Daniel has developed strong problem-solving skills, a collaborative mindset, and a commitment to scientific integrity. He is currently involved in a research program at the University of Calabar, where he is utilizing advanced computational tools to contribute to biosensor development, biomarkers, and drug modeling. He aims to further his knowledge through a Master’s degree, focusing on theoretical and computational modeling, with a drive to innovate in pharmaceutical and chemical research.

Professional Profile

Orcid

Summary of Suitability for the Award

MR. DANIEL GATIE MALU’s academic achievements, research experience, and dedication to utilizing advanced computational methods for drug design and bio-simulation, he is a strong candidate for the ‘Research for Excellence Award.’ His contributions to multidisciplinary research and his commitment to addressing critical global health issues through innovative scientific solutions make him well-suited for this recognition. His work has the potential for significant scientific impact, aligning well with the award’s criteria for research excellence.

🎓Education 

Daniel Gatie Malu holds a B.Sc. in Genetics and Biotechnology from the University of Calabar, Nigeria, graduating in 2024. His undergraduate thesis, titled “Molecular Modeling of the Spectroscopic Structural and Bioactive Potential of Azadirachta indica against Plasmodium falciparum”, highlights his deep interest in molecular modeling and drug discovery. Daniel explored phytochemical analysis, including GCMS, HPLC, FT-IR, and UV-Vis analysis, to investigate the bioactive potential of plant compounds. His academic focus was on theoretical and experimental approaches to understanding drug interactions with biological systems, utilizing modern computational techniques. The thesis also involved evaluating stability, reactivity, and binding potential of compounds, laying a strong foundation for his future research endeavors. This academic background equipped him with a solid understanding of computational biology, molecular chemistry, and bioinformatics, and he seeks to apply this knowledge to cutting-edge research in drug design and theoretical modeling.

 💼 Experience 

MR. DANIEL GATIE MALU has a diverse research background, starting with his industrial training at Biggmade Scientific Research Academy in 2023. There, he conducted serological tests and explored bioinformatics, focusing on drug-protein interactions. He also performed DNA extraction and plant tissue culture. Since November 2023, he has been part of the Computational and Bio-Simulation Research Group at the University of Calabar, where he is immersed in full-time research. Daniel leverages advanced computational tools such as Gaussian 16, AutoDock Vina, and PyMOL to conduct molecular docking and density functional theory (DFT) studies. His interdisciplinary research spans biosensors, biomarkers, and drug delivery systems. He has also contributed to academic publications and collaborated with peers across various scientific disciplines. Daniel’s mentorship of students and his role in academic projects demonstrate his commitment to fostering intellectual growth within his community.

🏅Awards and Honors 

Daniel Gatie Malu has earned recognition for his academic excellence and contributions to scientific research. In 2024, he became a student member of the Royal Society of Chemistry, which highlights his growing prominence in the field. His work has been instrumental in several key publications and research projects, earning him respect among his peers and mentors. His interdisciplinary research, particularly in molecular docking, density functional theory (DFT), and computational modeling, has been acknowledged within the scientific community. Throughout his academic career, Daniel has demonstrated a strong commitment to advancing knowledge in the fields of biotechnology and drug design, earning him multiple awards for his research contributions at the university level. His passion for innovative solutions in drug delivery and biosensor development has also positioned him as an emerging leader in computational biology and pharmaceutical research.

🌍 Research Focus 

Daniel Gatie Malu’s research focus lies at the intersection of computational chemistry, molecular biology, and drug discovery. He employs density functional theory (DFT) and molecular docking techniques to investigate drug-target interactions, specifically for diseases like Cystic Fibrosis, Huntington’s Disease, and various cancers (BRCA1/BRCA2). Daniel is particularly interested in the design of advanced drug delivery systems such as nanoparticles and liposomes for controlled release and targeted therapies. He also explores high-throughput screening (HTS) to identify active compounds from chemical libraries, focusing on improving the pharmacokinetic and safety profiles of potential drug candidates. Additionally, Daniel investigates the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of these compounds. His interdisciplinary research extends to biosensors and biomarkers, leveraging computational methods for innovative applications in both pharmaceuticals and environmental sciences.

📖 Publications Top Notes

How does the long G·G* Watson-Crick DNA base mispair comprising keto and enol tautomers of the guanine tautomerise? The results of a QM/QTAIM investigation.

 

Dr.Md. Mahmodol Hasan | Biological Sciences | Best Researcher Award

Dr.Md. Mahmodol Hasan | Biological Sciences | Best Researcher Award

Dr.Md. Mahmodol Hasan, University of Rajshahi, Bangladesh

Dr. Md. Mahmodol Hasan is a Bangladeshi professor in the Department of Agronomy and Agricultural Extension at the University of Rajshahi. He specializes in plant pathology and agricultural extension, with a focus on sustainable farming practices and the biocontrol of plant diseases. His research contributions have advanced understanding in wheat pathology, organic amendments, and the use of biocontrol agents like Trichoderma. His extensive experience in post-doctoral research, particularly in China, highlights his international collaboration efforts. A passionate educator and researcher, Dr. Hasan is dedicated to improving agricultural productivity and disease management.

Professional Profile

Orcid

Summary of Suitability for the Research for Best Researcher Award

MD. MAHMODOL HASAN’s significant contributions to plant pathology, sustainable farming techniques, and biological control of plant diseases, he is highly suitable for the Research for Best Researcher Award. His innovative work in integrating scientific research with practical solutions in agriculture makes him a deserving candidate. His extensive publication record and leadership in research further emphasize his excellence in the field, making him a strong contender for this prestigious award.

 🎓 Education

Dr. Hasan’s academic journey includes a Bachelor of Science in Agriculture (B.Sc. Ag.) from Bangladesh Agricultural University, followed by a Master of Science in Plant Pathology from the same institution. His postdoctoral research at Huazhong Agricultural University in China expanded his expertise in plant disease control, particularly in the use of endophytic Trichoderma species. His PhD from the University of Rajshahi focused on seed-borne wheat diseases and plant extracts for biocontrol. This well-rounded academic background supports his commitment to improving sustainable farming practices and advancing plant pathology research in Bangladesh and beyond.

 💼 Experience

Dr. Hasan’s professional career spans decades in academia and research, including his role as a professor at the University of Rajshahi. He has also conducted significant postdoctoral research in China, focusing on biological control agents for plant diseases. His experience includes working on national and international projects aimed at improving crop yields and disease management. He has mentored students, collaborated on interdisciplinary research, and contributed to global agricultural advancements. Dr. Hasan’s work has been published in numerous peer-reviewed journals, highlighting his impact on sustainable farming and plant pathology.

🏅Awards and Honors

Dr. Hasan has received numerous awards and recognitions for his contributions to agricultural science and plant pathology. His research in biocontrol, organic amendments, and sustainable farming practices has earned him recognition at both national and international levels. His postdoctoral research in China was a significant milestone, where he focused on biological control agents. Dr. Hasan has also received recognition for his teaching and mentorship roles, shaping future generations of agricultural scientists. His dedication to improving agricultural productivity through research and innovation continues to garner praise from academic and scientific communities.

🌍 Research Focus

Dr. Hasan’s research is primarily centered on plant pathology, with a particular focus on sustainable farming practices and biological control methods. His expertise lies in the use of Trichoderma species to combat seed-borne and soil-borne plant diseases, enhancing crop resilience and yield. His work spans organic amendments, probiotic use in soils, and the application of plasma technology to improve seed health. Through his research, Dr. Hasan aims to develop innovative and eco-friendly solutions to agricultural challenges, making farming more sustainable and productive for future generations.

  📖 Publication Top Notes

Qualitative Analysis of Nitrogen Flows within Farms in Darusa, Bangladesh
Changes in Soil Properties with Combined Use of Probiotic Cultures and Organic Farming Practices in Degraded Soils of Bangladesh

 

Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl, Universität Tübingen, Tübingen Deutschland ,Germany

Prof. Dr. Arnulf Stenzl is an Austrian-born urologist and global leader in urological oncology. He received his medical degree from Karl-Franzens University in Graz, Austria, in 1980 and subsequently trained in surgery and urology across Austria, Switzerland, and the United States. Since 2002, he has headed the Department of Urology at Eberhard-Karls University in Tübingen, Germany, where he oversees critical research on urological cancers. Prof. Stenzl’s contributions extend internationally, with membership in numerous editorial boards and global collaborations. He has played a pivotal role in shaping European urological policies as Secretary General of the European Association of Urology. His work has led to several groundbreaking patents in the field, furthering innovations in patient care.

Professional Profile

Education 

Prof. Dr. Arnulf Stenzl embarked on his academic journey in 1973 when he enrolled at Karl-Franzens University in Graz, Austria, where he earned his Doctor medicinae universalis (M.D.) in February 1980. His initial training spanned internal medicine, nephrology, and pathology at Landeskrankenhaus Klagenfurt and Karl-Franzens University. From 1984 to 1987, he undertook specialized training in urology, first at Karl-Franzens University, then further expanding his knowledge as a fellow in general urology and urologic oncology at the University of California, Los Angeles (UCLA). His education, which encompassed diverse fields such as trauma, vascular, and plastic surgery, provided him with a holistic understanding of medicine and surgery. His dedication to learning has been reflected in his ongoing research and innovative contributions to urology.

Experience 

Prof. Dr. Arnulf Stenzl has had a distinguished career spanning over three decades. After serving as an assistant professor at the University of Bern in Switzerland, he moved to the University of Innsbruck, Austria, where he eventually became vice-chairman of the Department of Urology. Since 2002, he has led the Department of Urology at Eberhard-Karls University Tübingen, Germany, overseeing the clinical, academic, and research arms of the institution. Prof. Stenzl has driven numerous groundbreaking research projects, collaborating with both academic and industrial partners. As Secretary General of the European Association of Urology, he has led European urological research and development initiatives. His expertise extends to cancer research, with numerous contributions to advancing treatment modalities for bladder and prostate cancer.

Awards and Honors 

Prof. Dr. Arnulf Stenzl’s career is marked by numerous prestigious awards and honors. He is an honorary member of several international urological societies, including the Bristol Urological Institute and the Canadian Urological Association. His service as President of the German Urological Association (2020-2021) highlights his leadership within the field. Additionally, his involvement as Chairman of the Scientific Congress Office for the European Association of Urology and his role on the Board of Directors of the European CanCer Organisation demonstrate his commitment to global urological advancement. Prof. Stenzl’s contributions to scientific literature have earned him multiple editorial board memberships. His innovative spirit is further evidenced by several patents, including implantable devices to treat urinary incontinence and risk prediction models for renal cell carcinoma.

Research Focus 

Prof. Dr. Arnulf Stenzl’s research is at the forefront of urological oncology, focusing on advanced treatment modalities for bladder and prostate cancers. His work delves into personalized cancer therapies, optimizing clinical outcomes through precision medicine approaches. A significant aspect of his research revolves around biomarker discovery and risk stratification, which aim to enhance early diagnosis and targeted treatment. He has contributed to pioneering studies in immunotherapy, including innovative techniques for bladder cancer surgery and the integration of novel hormonal therapies in prostate cancer treatment. Prof. Stenzl is also involved in collaborative research projects with industry, furthering the development of next-generation urological treatments. His innovative contributions have resulted in several patents, solidifying his standing as a leader in urological research and technology.


Publications top notes

  • Treatment Intensification With Novel Hormonal Therapy in Prostate Cancer 📚🧪
  • Sacituzumab Govitecan Efficacy in Urothelial Cancer 🧬🔬
  • Co-occurring BRCA2/SPOP Mutations and PARP Inhibitor Sensitivity 🧬⚕️
  • Epacadostat Plus Pembrolizumab for Urothelial Carcinoma 💉🧪
  • Impact of Teratoma on Survival in Germ Cell Cancer 🧫🩺
  • Sacituzumab Govitecan & Pembrolizumab in Urothelial Cancer 💊🧪
  • TROPHY-U-01 Study on Sacituzumab Govitecan in Metastatic Urothelial Cancer 🧬🔬
  • Efficacy of Darolutamide in Black Patients With Prostate Cancer ⚕️🩺
  • Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer 🧬💉